Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 3,252 | 3,522 | 3,254 | 3,742 | 3,545 |
| Cost of Goods | 1,340 | 1,335 | 1,233 | 1,548 | 1,466 |
| Gross Profit | 1,912 | 2,187 | 2,021 | 2,194 | 2,079 |
| Operating Expenses | 2,569 | 2,722 | 2,903 | 2,945 | 2,980 |
| Operating Income | -317 | -200 | -649 | -203 | -435 |
| Interest Expense | 0 | 1 | 1 | 0 | 0 |
| Other Income | 28 | 32 | -4 | 21 | 2 |
| Pre-tax Income | -289 | -169 | -654 | -182 | -433 |
| Net Income Continuous | -289 | -169 | -654 | -182 | -433 |
| Net Income | $-289 | $-169 | $-654 | $-182 | $-433 |
| EPS Basic Total Ops | -0.03 | -0.02 | -0.06 | -0.02 | -0.04 |
| EPS Basic Continuous Ops | -0.03 | -0.02 | -0.06 | -0.02 | -0.04 |
| EPS Diluted Total Ops | -0.03 | -0.02 | -0.06 | -0.02 | -0.04 |
| EPS Diluted Continuous Ops | -0.03 | -0.02 | -0.06 | -0.02 | -0.04 |
| EPS Diluted Before Non-Recurring Items | -0.03 | -0.02 | -0.06 | N/A | N/A |
| EBITDA(a) | $-282 | $-166 | $-598 | $-147 | $-382 |